{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T11:08:27Z","timestamp":1778238507337,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jtha.2024.03.030","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T22:05:44Z","timestamp":1715205944000},"page":"2227-2233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Perioperative management and outcomes in patients receiving low-dose rivaroxaban and\/or aspirin: a subanalysis of the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5288-0394","authenticated-orcid":false,"given":"James D.","family":"Douketis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qilong","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Muehlhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael K.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo P.","family":"Maggioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"Eikelboom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.03.030_bib1","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1016\/j.chest.2022.07.025","article-title":"Perioperative management of antithrombotic therapy: an American College of Chest Physicians clinical practice guideline","volume":"162","author":"Douketis","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2024.03.030_bib2","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1161\/CIRCULATIONAHA.117.031457","article-title":"Periprocedural outcomes of direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation","volume":"138","author":"Nazha","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.03.030_bib3","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.112.105221","article-title":"Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates","volume":"126","author":"Siegal","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.03.030_bib4","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1161\/CIRCULATIONAHA.113.005754","volume":"129","author":"Sherwood","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.03.030_bib5","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1093\/eurheartj\/eht557","article-title":"Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry","volume":"35","author":"Beyer-Westendorf","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2024.03.030_bib6","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.03.030_bib7","first-page":"560","article-title":"Canadian Cardiovascular Society 2022 guidelines for peripheral arterial disease","volume":"38","author":"Primary","year":"2022","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jtha.2024.03.030_bib8","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/jth.12282","article-title":"Periprocedural antiplatelet therapy: recommendations for standardized reporting in patients on antiplatelet therapy: communication from the SSC of the ISTH","volume":"11","author":"Spyropoulos","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.030_bib9","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/jth.14598","volume":"17","author":"Spyropoulos","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.030_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bpg.2012.01.013","article-title":"Role of ASA in the primary and secondary prevention of cardiovascular events","volume":"26","author":"Casado-Arroyo","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jtha.2024.03.030_bib11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.36290\/vnl.2022.050","article-title":"Acetylsalicylic acid in primary prevention of cardiovascular disease","volume":"68","author":"Mikl\u00edk","year":"2022","journal-title":"Vnitr Lek"},{"key":"10.1016\/j.jtha.2024.03.030_bib12","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJMoa1401105","article-title":"Aspirin in patients undergoing noncardiac surgery","volume":"370","author":"Devereaux","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.03.030_bib13","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jamainternmed.2019.2431","article-title":"Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant","volume":"179","author":"Douketis","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jtha.2024.03.030_bib14","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1501035","article-title":"Perioperative bridging anticoagulation in patients with atrial fibrillation","volume":"373","author":"Douketis","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.03.030_bib15","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1538-7836.2010.03781.x","article-title":"Risk of stroke after surgery in patients with and without chronic atrial fibrillation","volume":"8","author":"Kaatz","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.030_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/03007995.2022.2141962","article-title":"Protocols for perioperative management of direct oral anticoagulants in hospitals: opportunities for improvement","volume":"39","author":"Mitrovic","year":"2023","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jtha.2024.03.030_bib17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jacc.2016.04.042","article-title":"Management of periprocedural anticoagulation: a survey of contemporary practice","volume":"68","author":"Flaker","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2024.03.030_bib18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11239-013-0960-6","article-title":"The equipoise of perioperative anticoagulation management: a Canadian cross-sectional survey","volume":"37","author":"Skeith","year":"2014","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2024.03.030_bib19","first-page":"17","article-title":"Canadian Cardiovascular Society guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery","volume":"33","author":"Duceppe","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jtha.2024.03.030_bib20","article-title":"Predictors of bleeding in the perioperative anticoagulant use for surgery evaluation study","volume":"9","author":"Tafur","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jtha.2024.03.030_bib21","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1378\/chest.09-2603","article-title":"Safety of uninterrupted anticoagulation in patients requiring elective coronary angiography with or without percutaneous coronary intervention: a systematic review and metaanalysis","volume":"138","author":"Jamula","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2024.03.030_bib22","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/j.1538-7836.2008.03080.x","article-title":"Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide","volume":"6","author":"Jamula","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.030_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.thromres.2016.01.004","article-title":"Urgent surgery or procedures in patients taking dabigatran or warfarin: analysis of perioperative outcomes from the RE-LY trial","volume":"139","author":"Douketis","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.03.030_bib24","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.2174\/138161210793563338","article-title":"Pharmacologic properties of the new oral anticoagulants: a clinician-oriented review with a focus on perioperative management","volume":"16","author":"Douketis","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jtha.2024.03.030_bib25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1477-9560-11-10","article-title":"Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring","volume":"11","author":"Mueck","year":"2013","journal-title":"Thromb J"},{"key":"10.1016\/j.jtha.2024.03.030_bib26","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1538-7836.2012.04641.x","article-title":"Reversal of the anti-platelet effects of aspirin and clopidogrel","volume":"10","author":"Li","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.030_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.curtheres.2014.02.002","article-title":"Recovery time of platelet function after aspirin withdrawal","volume":"76","author":"Lee","year":"2014","journal-title":"Curr Ther Res Clin Exp"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624002575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624002575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T01:11:11Z","timestamp":1754010671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624002575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1538783624002575"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.03.030","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative management and outcomes in patients receiving low-dose rivaroxaban and\/or aspirin: a subanalysis of the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}